American Herbal Products Association (AHPA) > News

AHPA submits vinpocetine comments to FDA

November 2016: HHS Secretary has authority to create exceptions to dietary supplement definition

The American Herbal Products Association (AHPA) recommends the Secretary of Health and Human Services (HHS) consider initiating rulemaking to declare vinpocetine to be lawful dietary ingredient in comments submitted to the Food and Drug Administration (FDA).

AHPA Presents at Korea-China Joint International Phytonutrient Symposium

AHPA President Michael McGuffin presents overview of regulatory landscape for botanical raw materials

AHPA President Michael McGuffin presented an overview of U.S. regulations for botanical raw materials at the 2016 Korea-China Joint International Phytonutrient Symposium organized jointly by the Korean Society of Food Science and Technology (KoSFoST) and the Chinese Nutrition Society and held on October 27 in Seoul, Korea.

Update on international supplement regulations

IADSA October 2016 Newsflash

IADSA is an association focused on the globalization of food supplement markets and regulatory challenges. This issue of the IADSA Newsflash includes an update on the European Commission (EC) request of the European Food Safety Authority (EFSA) to provide a scientific opinion on the safety of green tea catechins with a proposed deadline of October 2017.

"Incidental DNA fragments" may be misinterpreted using Next Generation Sequencing (NGS)

October 19. 2016: A caution to industry and regulators

This article, "A caution to industry and regulators - 'Incidental DNA fragments' may be misinterpreted using Next Generation Sequencing (NGS)," is authored by Dr. Steven Newmaster, Professor, Botany & Genetics/Genomics at the University of Guelph, Dr. Subramanyam Ragupathy, Senior Scientist, NHP Molecular Diagnostics at the Biodiversity Institute of Ontario, and Dr. Robert Hanner, Chief Technology Officer (CTO) at TRU-ID Ltd. These leading DNA experts detai challenges and pitfalls of DNA analysis used to verify the identity of herbal ingredients.

AHPA expresses concern about DEA using emergency scheduling authority to temporarily classify herb as schedule I substance

September 2016: AHPA requests DEA to delay action

The American Herbal Products Association (AHPA) sent a letter to the U.S. Drug Enforcement Agency (DEA) urging the agency to reconsider using its emergency scheduling authority to temporarily place constituents of the herb kratom into schedule I of the Controlled Substances Act (CSA).

Biennial food facility registration renewal begins October 1

Facilities must register by December 1

Domestic and foreign facilities that manufacture, process, pack, or hold food for consumption in the United States are required to register with the Food and Drug Administration (FDA). All entities required to register must renew their registration from October 1 through December 31 every even-numbered year. If the facility registration is not renewed by 11:59 PM on December 31, 2016, the registration is considered expired.

FDA Seeks Comment on Tentative Conclusion that Vinpocetine Is not a Dietary Ingredient

FDA maintains vinpocetine is a synthetic compound

A Food and Drug Administration (FDA) notice scheduled to be published tomorrow in the Federal Register requests comments on the agency's tentative conclusion that vinpocetine is not a dietary ingredient and is excluded from the definition of a dietary supplement.

Report from the 2016 Conference of Western Attorneys General Annual Meeting

By Douglas F. Gansler

In January, AHPA and UNPA launched a joint campaign to develop working relationships with state attorneys general (AG) and educate them about the herbal supplement industry to ensure they have an accurate understanding of the industry. Former Maryland Attorney General and Past President of the National Association of Attorneys General. Gansler was hired to help deliver information and expertise about the industry to his colleagues.

FDA Releases Revised Draft of NDI Guidance

August 2016: Revised draft replaces FDA’s 2011 draft

The Food and Drug Administration (FDA) today released revised draft guidance for new dietary ingredients (NDIs) to be published in the Federal Register on Friday. The revised draft replaces FDA’s 2011 draft.

Congress Clears Federal Mandatory GMO Labeling Bill to Be Signed into Law

Federal law would preempt state GMO labeling requirements

AHPA President Michael McGuffin comments on bill's passage

Alerts

Subscribe>>

AHPA Alerts